Article Details

OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of ...

Retrieved on: 2021-04-22 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of .... View article details on hiswai: https://www.globenewswire.com/news-release/2021/04/22/2215011/0/en/OWP-Pharmaceuticals-Announces-Patent-Application-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disord.html

Excerpt

NAPERVILLE, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up